» Articles » PMID: 15979679

Early Detection of Dominant Env-specific and Subdominant Gag-specific CD8+ Lymphocytes in Equine Infectious Anemia Virus-infected Horses Using Major Histocompatibility Complex Class I/peptide Tetrameric Complexes

Overview
Journal Virology
Specialty Microbiology
Date 2005 Jun 28
PMID 15979679
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Cytotoxic T lymphocytes (CTL) are critical for control of lentiviruses, including equine infectious anemia virus (EIAV). Measurement of equine CTL responses has relied on chromium-release assays, which do not allow accurate quantitation. Recently, the equine MHC class I molecule 7-6, associated with the ELA-A1 haplotype, was shown to present both the Gag-GW12 and Env-RW12 EIAV CTL epitopes. In this study, 7-6/Gag-GW12 and 7-6/Env-RW12 MHC class I/peptide tetrameric complexes were constructed and used to analyze Gag-GW12- and Env-RW12-specific CTL responses in two EIAV-infected horses (A2164 and A2171). Gag-GW12 and Env-RW12 tetramer-positive CD8+ cells were identified in nonstimulated peripheral blood mononuclear cells as early as 14 days post-EIAV inoculation, and frequencies of tetramer-positive cells ranged from 0.4% to 6.7% of nonstimulated peripheral blood CD8+ cells during the 127-day study period. Although both horses terminated the initial viremic peak, only horse A2171 effectively controlled viral load. Neutralizing antibody was present during the initial control of viral load in both horses, but the ability to maintain control correlated with Gag-GW12-specific CD8+ cells in A2171. Despite Env-RW12 dominance, Env-RW12 escape viral variants were identified in both horses and there was no correlation between Env-RW12-specific CD8+ cells and control of viral load. Although Gag-GW12 CTL escape did not occur, a Gag-GW12 epitope variant arose in A2164 that was recognized less efficiently than the original epitope. These data indicate that tetramers are useful for identification and quantitation of CTL responses in horses, and suggest that the observed control of EIAV replication and clinical disease was associated with sustained CTL recognition of Gag-specific epitopes.

Citing Articles

Key Factors and Parameter Ranges for Immune Control of Equine Infectious Anemia Virus Infection.

Hull-Nye D, Meadows T, Smith S, Schwartz E Viruses. 2023; 15(3).

PMID: 36992401 PMC: 10058099. DOI: 10.3390/v15030691.


Induction of tolerance against the arthritogenic antigen with type-II collagen peptide-linked soluble MHC class II molecules.

Park Y, Jung S, Park S BMB Rep. 2016; 49(6):331-6.

PMID: 26779996 PMC: 5070721. DOI: 10.5483/bmbrep.2016.49.6.207.


Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies.

Liu C, Cook S, Craigo J, Cook F, Issel C, Montelaro R Vet Immunol Immunopathol. 2014; 161(3-4):161-9.

PMID: 25176006 PMC: 4337894. DOI: 10.1016/j.vetimm.2014.08.001.


The determination of in vivo envelope-specific cell-mediated immune responses in equine infectious anemia virus-infected ponies.

Liu C, Cook F, Cook S, Craigo J, Even D, Issel C Vet Immunol Immunopathol. 2012; 148(3-4):302-10.

PMID: 22795699 PMC: 4337896. DOI: 10.1016/j.vetimm.2012.06.018.


Expression, refolding and preliminary X-ray crystallographic analysis of equine MHC class I molecule complexed with an EIAV-Env CTL epitope.

Yao S, Qi J, Liu J, Chen R, Pan X, Li X Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012; 68(Pt 1):20-3.

PMID: 22232164 PMC: 3253827. DOI: 10.1107/S1744309111038139.


References
1.
ONeill T, Kydd J, Allen G, Wattrang E, Mumford J, Hannant D . Determination of equid herpesvirus 1-specific, CD8+, cytotoxic T lymphocyte precursor frequencies in ponies. Vet Immunol Immunopathol. 1999; 70(1-2):43-54. DOI: 10.1016/s0165-2427(99)00037-9. View

2.
Breathnach C, Soboll G, Suresh M, Lunn D . Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets. Vet Immunol Immunopathol. 2004; 103(3-4):207-15. DOI: 10.1016/j.vetimm.2004.09.024. View

3.
Hammond S, Li F, McKeon Sr B, Cook S, Issel C, Montelaro R . Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus. J Virol. 2000; 74(13):5968-81. PMC: 112093. DOI: 10.1128/jvi.74.13.5968-5981.2000. View

4.
McGuire T, Leib S, Lonning S, Zhang W, Byrne K, Mealey R . Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses. J Gen Virol. 2000; 81(Pt 11):2735-2739. DOI: 10.1099/0022-1317-81-11-2735. View

5.
Kostense S, Ogg G, Manting E, Gillespie G, Joling J, Vandenberghe K . High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function. Eur J Immunol. 2001; 31(3):677-86. DOI: 10.1002/1521-4141(200103)31:3<677::aid-immu677>3.0.co;2-m. View